(Q46487408)
Statements
1 reference
Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial). (English)
1 reference
1 reference
PierFranco Conte
1 reference
Valentina Guarneri
1 reference
Antonio Frassoldati
1 reference
Gordana Jovic
1 reference
Simona Giovannelli
1 reference
Cristina Oliva
1 reference
1 April 2008
1 reference
8
1 reference
2
1 reference
192-194
1 reference